4Filing Date: Aug 18, 2026

J&J (JNJ)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0000200406-26-000175
Total Value$5.69M
Trades3
Insiders1

Transaction Details

Taubert Jennifer L
EVP, WWC. Innovative Medicine·Direct
Exercise · Acquire
Common Stock
Shares+15.00K
Price$115.67
Total Value$1.74M
Shares Owned After209.45K
Transaction DateAug 17, 2026
Taubert Jennifer L
EVP, WWC. Innovative Medicine·Direct
Exercise · Dispose
Employee Stock Options (Right to Buy)Derivative
Shares-15.00K
Price$0.00
Total Value$0
Shares Owned After28.71K
Transaction DateAug 17, 2026
ExpiresFeb 13, 2027
Footnotes ▸

Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.

Taubert Jennifer L
EVP, WWC. Innovative Medicine·Direct
Sell · Dispose
Common Stock
Shares-15.00K
Price$263.36
Total Value$3.95M
Shares Owned After194.45K
Transaction DateAug 17, 2026
Footnotes ▸

This transaction was executed in multiple trades at prices ranging from $263.30 to $263.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Post-Transaction Holdings

Taubert Jennifer L · EVP, WWC. Innovative Medicine
SecuritySharesChange
Common Stock209.45K-
Employee Stock Options (Right to Buy)28.71K-15.00K (-34.32%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-17 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: JOHNSON & JOHNSON (JNJ) CIK: 0000200406 --- Reporting Owner --- Name: Taubert Jennifer L CIK: 0001745938 Role: Officer (EVP, WWC. Innovative Medicine) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-08-17 | Code: M (Exercise of derivative) Shares: +15,000 | Price: $115.67 Total Value: $1,735,050.00 Shares Owned After: 209,451.001 | Ownership: D (Direct) [Transaction #2] Security: Common Stock Date: 2026-08-17 | Code: S (Open market sale) Shares: -15,000 | Price: $263.36 Total Value: $3,950,400.00 Shares Owned After: 194,451.001 | Ownership: D (Direct) Footnotes: [F1] This transaction was executed in multiple trades at prices ranging from $263.30 to $263.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. --- Derivative Transactions --- [Transaction #1] Security: Employee Stock Options (Right to Buy) Date: 2026-08-17 | Code: M (Exercise of derivative) Shares: -15,000 | Price: $0.00 Exercisable: N/A | Expires: 2027-02-13 Shares Owned After: 28,712 | Ownership: D (Direct) Footnotes: [F2] Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date. --- Footnotes (Complete Index) --- F1: This transaction was executed in multiple trades at prices ranging from $263.30 to $263.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date. --- Signature --- /s/ /s/ Joleen Morgan, as attorney-in-fact for Jennifer Taubert (2026-08-18)

keid analysis is for reference only and does not constitute investment advice.